SCHEMBL7369750

SCHEMBL7369750

COc1c([N+](=O)[O-])cc(C#N)c(Cl)c1O

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
VCAM1 P19320 4/20 0.44
TPMT P51580 1/20 0.43
GPR35 Q9HC97 3/20 0.41
EGFR P00533 1/20 0.41
GRM6 O15303 1/20 0.39
GRIA1 P42261 1/20 0.39
GRIA2 P42262 1/20 0.39
GRIA3 P42263 1/20 0.39
GRIA4 P48058 1/20 0.39
HTT P42858 2/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7450595 0.96 GPR35 (0.42) VCAM1TPMTGPR35EGFRGRM6
SCHEMBL7373383 0.84 TPMT (0.44) VCAM1TPMTGPR35EGFRGRM6
SCHEMBL8728250 0.82 GPR35 (0.53) VCAM1GPR35GRM6GRIA1GRIA2
SCHEMBL7371372 0.75 KDM4E (0.49) TPMTGPR35ALDH1A1MAPT
SCHEMBL2958280 0.75 VCAM1 (0.51) VCAM1GPR35GRM6GRIA1GRIA2
SCHEMBL16901738 0.73 GPR35 (0.44) VCAM1TPMTGPR35GRM6GRIA1
SCHEMBL9736340 0.73 VCAM1 (0.49) VCAM1TPMTGPR35GRM6GRIA1
SCHEMBL9395751 0.72 IMPDH2 (0.44) VCAM1TPMTGPR35GRM6GRIA1
SCHEMBL9005399 0.72 TPMT (0.49) VCAM1TPMTGPR35ALDH1A1MAPT
SCHEMBL3648533 0.72 MERTK (0.48) VCAM1EGFRHTTALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed